Log In
Print
BCIQ
Print
Print this Print this
 

L-BLP25 (formerly Stimuvax)

Also known as: BLP25 liposome vaccine

  Manage Alerts
Collapse Summary General Information
Company Oncothyreon Inc.
DescriptionLiposomal vaccine containing a synthetic 25 amino acid peptide sequence from mucin 1 (MUC1; CD227)
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of ActionVaccine
Latest Stage of DevelopmentPhase III
IndicationNon-small cell lung cancer (NSCLC)
Partner

Merck KGaA; Ono Pharmaceutical Co. Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today